Articles

Cyclin-dependent kinase 9 as a potential specific molecular target in NK-cell leukemia/lymphoma

Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan;Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan;Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Tumor Immunology, Aichi Medical University School of Medicine, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Department of Virology, Division of Medical Science, Medical Research Institute, Tokyo Medical and Dental University, Japan
Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, Japan
Bayer Yakuhin, Ltd., Osaka, Japan
Bayer AG Pharmaceuticals Division, Berlin, Germany
Department of Tumor Immunology, Aichi Medical University School of Medicine, Japan
Cancer Science Institute of Singapore, National University of Singapore
Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Japan
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.191395